Since 2006, the Phospholipid Research Center has been funding research into phospholipid excipients in drugs

Drug Delivery
All categoriesBasic ResearchDepotDermalDrug DeliveryOralParenteral
Self-assembling (Lipid)Nanoparticles
All aggregatesnano plasma membrane vesicle-lipid nanoparticle (nPMV-LNP) hybridsBolalipidsSynthetic single-chain bolalipids (SSCBs)CochleatesColloidsEmulsionsExosomesExtrudatesImplantsLamellaeLipid dispersionsLipodisksLiposomesMicrobubblesMicroparticlesMixed Micelles / MicellesMonolayerNanofibersSelf-assembling (Lipid)NanoparticlesSelf-emulsifying SystemsSolid Dispersions / DispersionsTablets
Any status
finishedongoing
Dermal, Drug DeliveryFormulation of lipid nanoparticles (LNP) encapsulating micro-RNA for topical treatment of high-grade squamous intraepithelial lesions (HSIL) lesion

Dr. Mohamadreza Amin – Erasmus University Medical Center Rotterdam, The Netherlands

Since 2024
Drug Delivery, ParenteralTherapeutic RNA delivery by Extracellular Vesicle mimetics

Assoc. Prof. Dr. Pieter Vader – University Medical Center Utrecht, The Netherlands

Since 2024
Drug Delivery, ParenteralImproving endosomal escape of lipid nanoparticles

Dr. Christoffer Åberg – University of Groningen/The Netherlands and Prof. Dr. Enrico Mastrobattista – Utrecht University/The Netherlands

Since 2023
Drug Delivery, ParenteralReceptor-targeted lipid nanoparticles for mRNA delivery into T lymphocytes

Prof. Dr. Christian Buchholz – Paul-Ehrlich-Institut/Germany

Since 2023
Drug Delivery, ParenteralLipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy – part II

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

2020-2022
Drug Delivery, ParenteralLipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

2017–2019